Get the latest tech news
Immunotherapy trial helps cancer patients with tumours live 40% longer
Experts praise groundbreaking results from therapy using genetically modified Car T-cells
Cancer patients treated with a pioneering immunotherapy that genetically modifies their own cells to wipe out tumours live 40% longer, according to “exciting” and “groundbreaking” results from a world-first clinical trial. He added: “This is a very important ‘plant the flag’ publication that should rally the cancer research community to push forward toward improving the lives of patients [with] solid tumours.” Results from that trial are expected to show Car T-cell can shrink tumours in glioblastoma, an aggressive and fast-growing brain cancer, and help patients live much longer.
Or read this on r/technology